Oncaspar Injection, Solution
Product Images NDC 72694-954

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Oncaspar (NDC 72694-954). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Servier Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Oncaspar 01)

This appears to be a table or graph related to Asparagine and L-Asparaginase treatment, with the X-axis representing "Days After First Dose of L-Asparaginase" and the Y-axis possibly representing dosage or efficacy. However, without further context or more readable data, it is difficult to provide a more detailed description.*

FDA Label Image

Principal Display Panel (5 mL Vial Carton)

This text describes a medication called ONCASPAR, which is an injection of the drug pegaspargase used for intravenous or intramuscular administration. The medication comes in a single-use vial and should be discarded if any unused portion remains. The dosage instructions and storage information are included on the package insert. ONCASPAR is a registered trademark of Servier IP UK Ltd, and the medication is manufactured by Servier Pharmaceuticals LLC. The active ingredient in ONCASPAR is 6.5 mg of L-asparaginase protein conjugated with multiple 5603 MPEGS per mL, manufactured using E. coli. The medication does not contain any preservatives.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.